BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 15805250)

  • 1. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
    Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M
    Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in Human Gliomas.
    Kunitz A; Wolter M; van den Boom J; Felsberg J; Tews B; Hahn M; Benner A; Sabel M; Lichter P; Reifenberger G; von Deimling A; Hartmann C
    Brain Pathol; 2007 Oct; 17(4):363-70. PubMed ID: 17610521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification.
    Misawa A; Inoue J; Sugino Y; Hosoi H; Sugimoto T; Hosoda F; Ohki M; Imoto I; Inazawa J
    Cancer Res; 2005 Nov; 65(22):10233-42. PubMed ID: 16288011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent epigenetic inactivation of the SLIT2 gene in gliomas.
    Dallol A; Krex D; Hesson L; Eng C; Maher ER; Latif F
    Oncogene; 2003 Jul; 22(29):4611-6. PubMed ID: 12881718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
    Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EMP3 as a candidate tumor suppressor gene for solid tumors.
    Fumoto S; Tanimoto K; Hiyama E; Noguchi T; Nishiyama M; Hiyama K
    Expert Opin Ther Targets; 2009 Jul; 13(7):811-22. PubMed ID: 19466912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.
    Ropero S; Setien F; Espada J; Fraga MF; Herranz M; Asp J; Benassi MS; Franchi A; Patiño A; Ward LS; Bovee J; Cigudosa JC; Wim W; Esteller M
    Hum Mol Genet; 2004 Nov; 13(22):2753-65. PubMed ID: 15385438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMP3 overexpression is associated with oligodendroglial tumors retaining chromosome arms 1p and 19q.
    Li KK; Pang JC; Chung NY; Ng YL; Chan NH; Zhou L; Poon WS; Ng HK
    Int J Cancer; 2007 Feb; 120(4):947-50. PubMed ID: 17187361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation.
    Carén H; Ejeskär K; Fransson S; Hesson L; Latif F; Sjöberg RM; Krona C; Martinsson T
    Mol Cancer; 2005 Mar; 4(1):10. PubMed ID: 15740626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.
    Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F
    Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LOH 19q indicates shorter disease progression-free interval in low-grade oligodendrogliomas with EMP3 methylation.
    Pasini A; Iorio P; Bianchi E; Cerasoli S; Cremonini AM; Faedi M; Guarnieri C; Guiducci G; Riccioni L; Molinari C; Rengucci C; Calistri D; Giordano E
    Oncol Rep; 2012 Dec; 28(6):2271-7. PubMed ID: 22992787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation of the EMP3 gene in a series of 229 human gliomas.
    Mellai M; Piazzi A; Caldera V; Annovazzi L; Monzeglio O; Senetta R; Cassoni P; Schiffer D
    Biomed Res Int; 2013; 2013():756302. PubMed ID: 24083241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma.
    Kongkham PN; Northcott PA; Ra YS; Nakahara Y; Mainprize TG; Croul SE; Smith CA; Taylor MD; Rutka JT
    Cancer Res; 2008 Dec; 68(23):9945-53. PubMed ID: 19047176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMP3 as a tumor suppressor gene for esophageal squamous cell carcinoma.
    Fumoto S; Hiyama K; Tanimoto K; Noguchi T; Hihara J; Hiyama E; Noguchi T; Nishiyama M
    Cancer Lett; 2009 Feb; 274(1):25-32. PubMed ID: 18823699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development.
    Lusher ME; Lindsey JC; Latif F; Pearson AD; Ellison DW; Clifford SC
    Cancer Res; 2002 Oct; 62(20):5906-11. PubMed ID: 12384556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis.
    Carlsson E; Krohn K; Ovaska K; Lindberg P; Häyry V; Maliniemi P; Lintulahti A; Korja M; Kivisaari R; Hussein S; Sarna S; Niiranen K; Hautaniemi S; Haapasalo H; Ranki A
    Genes Chromosomes Cancer; 2013 Feb; 52(2):191-201. PubMed ID: 23097141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.
    Yang Q; Zage P; Kagan D; Tian Y; Seshadri R; Salwen HR; Liu S; Chlenski A; Cohn SL
    Clin Cancer Res; 2004 Dec; 10(24):8493-500. PubMed ID: 15623630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
    Kikuchi R; Tsuda H; Kozaki K; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
    Cancer Res; 2008 Jul; 68(13):5067-75. PubMed ID: 18593905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of CpG island hypermethylation of caspase-8 in neuroblastoma using an oligonucleotide array.
    Kamimatsuse A; Matsuura K; Moriya S; Fukuba I; Yamaoka H; Fukuda E; Kamei N; Hiyama K; Sueda T; Hiyama E
    Pediatr Blood Cancer; 2009 Jul; 52(7):777-83. PubMed ID: 19260109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.